To evaluate the effect of Wobe mugos hydrolytic enzyme therapy on inflammation induced by external radiotherapy in patients of head and neck cancers

Bahrain Medical Bulletin

Volumn 23, Issue 3, 2001, Pages 116-118

  Koul, R ^a   Choudharay, V ^a  

^a SGPT Cancer Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; HYDROLASE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME THERAPY; EVALUATION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MICROCIRCULATION; MOUTH CANCER; MUCOSA INFLAMMATION; NUTRITIONAL STATUS; OROPHARYNX CANCER; PATIENT COMPLIANCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TABLET; VASCULARIZATION;

EID: 0034765898     PISSN: 10128298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Enzymes as agent for the treatment of various disease
2. Radiation complication in edentulous patients
3. Inflammation and its treatment with hydrolytic enzymes and rutin
4. Enzyme treatment in diseases of veins
5. Hydrolytic enzyme therapy in pelvic inflammatory diseases
6. The action of hydrolytic enzymes in traumatology. Results after two prospective randomized double blind studies
7. Hydrolytic enzyme therapy in treatment of HIV positive disease